IBERE PHARMACEUTICALS's ticker is IBERWS and the CUSIP is G46843119. A total of 2 filers reported holding IBERE PHARMACEUTICALS in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $525 | -89.5% | 53,578 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | +25.0% | 53,578 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -63.6% | 53,578 | -1.1% | 0.00% | – |
| Q1 2022 | $11,000 | -62.1% | 54,178 | 0.0% | 0.00% | – |
| Q4 2021 | $29,000 | -27.5% | 54,178 | -20.0% | 0.00% | – |
| Q3 2021 | $40,000 | – | 67,722 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integrity Capital Management (HK) Ltd | 38,428 | $3,000 | 4.69% |
| Knott David M Jr | 18,000 | $207,000 | 0.09% |
| Radcliffe Capital Management, L.P. | 150,000 | $1,472,000 | 0.03% |
| MARSHALL WACE, LLP | 224,997 | $2,207,000 | 0.01% |
| TEGEAN CAPITAL MANAGEMENT, LLC | 68,565 | $4,002 | 0.00% |
| Ayrton Capital LLC | 28,393 | $2,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 13,499 | $132,000 | 0.00% |
| COWEN AND COMPANY, LLC | 218,283 | $17,000 | 0.00% |
| Lynwood Capital Management Inc. | 9,800 | $1,000 | 0.00% |
| EHP Funds Inc. | 94,269 | $8,000 | 0.00% |